---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-095085"
form_type: "8-K"
ticker: "SLDB"
cik: "0001707502"
company_name: "Solid Biosciences Inc."
filed_at: "2022-04-04T23:59:59+00:00"
generated_at: "2026-06-26T09:50:53.930278+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Solid Biosciences board adopts new Code of Business Conduct and Ethics

## Summary
- Board approved new Code of Business Conduct and Ethics on March 30, 2022.
- New code replaces prior code in its entirety; no explicit or implicit waivers granted.
- Code applies to all employees, officers, directors of Solid Biosciences and its subsidiaries.
- Full text posted at https://investors.solidbio.com/governance/governance-documents.

## SEC filing metadata
- accession: 0001193125-22-095085
- form_type: 8-K
- ticker: SLDB
- cik: 0001707502
- company_name: Solid Biosciences Inc.
- filed_at: 2022-04-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1707502/000119312522095085/0001193125-22-095085-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1707502/000119312522095085/d272083d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-095085
- JSON: https://secwatch.observer/filing/0001193125-22-095085.json
- Plain text: https://secwatch.observer/filing/0001193125-22-095085.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.